Posted in | News | Mining Business

K92 Mining Receives Clearance to Resume Underground Operations

K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQB:  KNTNF) announces that it has commenced preparations to resume underground operations within two days, following the receipt of a letter from the Mineral Resources Authority (“MRA”) of Papua New Guinea vacating the Form 29 that was issued on March 13, 2024 (see March 19, 2024 Press Release).

The receipt of the letter vacating Form 29, follows a presentation by an Independent Safety Auditor to the MRA. Findings from the audit indicated that the Underground Safety Management Plan is good, conforms to criteria in ISO45001 and has been implemented. The Safety Auditor also did not find any substandard document, process or system, and noted that the Underground Safety Management Plan is comparable to other operations in Australia and Asia.

John Lewins, Chief Executive Officer and Director stated, “Safety is, has and always will be K92’s number one priority, and I am pleased with the results of the Independent Safety Audit which are also a reflection of the significant investment and focus by the team on site, which has further intensified since mid-2023.

While we are pleased with the positive safety audit findings, I want to emphasize that K92 is always proactively striving for better and will continue to relentlessly pursue its goal of zero harm.”

The Company reiterates its 2024 Operational Guidance, and notes that the temporary suspension of underground operations since March 10, 2024 will have a moderate impact on Q1 and Q2 production.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.